Evidence map›Paper›PMID 38328493›Full record

ArticleOpen forum infectious diseases2024

Breaking Barriers: A Single-Center Real-World Experience With Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement.

Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez, Armando Paez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sara BrennerDivision of Infectious Diseases, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0009-0004-0790-101X
Alexander KneeDepartment of Medicine, and Epidemiology/Biostatistics Research Core, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.ORCID https://orcid.org/0000-0001-5656-6095
Douglas SalvadorDivision of Infectious Diseases, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Erica HousmanDepartment of Pharmacy, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Gladys FernandezDepartment of Surgery, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Armando PaezDivision of Infectious Diseases, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.ORCID https://orcid.org/0000-0002-1075-8865
University of Massachusetts Chan Medical School · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a retrospective exploratory study evaluating factors associated with selection to receive and infusion with coronavirus disease 2019 monoclonal antibodies. While priority was given to high-risk patients, patients with increased Social Vulnerability Index scores were less likely to present for infusion, raising concern that social factors created barriers to treatment.

Indexed as

COVID-19health disparitiesmonoclonal antibodiespandemicSocial Vulnerability Index (SVI)

Identifiers

PMID38328493
PMCPMC10847809
OpenAlexW4390259032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.